These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 546656)

  • 1. Resistance of tubercle bacilli: a brief review in relation to a recent study in Ethiopia.
    Teklu B
    Ethiop Med J; 1979 Oct; 17(4):123-5. PubMed ID: 546656
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
    Pattyn SR; Keterew W; Hadgu AG; van den Breen L
    Ethiop Med J; 1979 Oct; 17(4):119-22. PubMed ID: 546655
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to streptomycin, isoniazid and para-aminosalicylic acid of tubercle bacilli from patients with pulmonary tuberculosis in Sri Lanka.
    Pinto MR; Arseculeratne SN; Dasan P; Uragoda CG
    Ceylon Med J; 1982 Jun; 27(2):69-74. PubMed ID: 6819092
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian survey to determine the rate of drug resistance to isoniazid, PAS and streptomycin in newly detected untreated tuberculosis patients and retreatment cases.
    Hershfield ES; Eidus L; Helbecque DM
    Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):387-93. PubMed ID: 115802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new disc technique for drug sensitivity test of tubercle bacilli.
    Kudoh S; Kudoh T; Yoshikawa S
    Acta Tuberc Pneumol Scand; 1965; 46(3):207-19. PubMed ID: 4956376
    [No Abstract]   [Full Text] [Related]  

  • 6. [Virulence of INH-resistant tubercle bacilli to the human body. I. Infectiousness of INH-resistant tubercle bacilli].
    Murata A
    Kekkaku; 1967 Sep; 42(9):343-8. PubMed ID: 4966768
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacteria resistant to streptomycin, P.A.S. and isoniazid.
    Brown LR; Courteau RD; Davies JC; Stoughton RR; Weitz A
    Cent Afr J Med; 1973 Jun; 19(6):116-9. PubMed ID: 4125461
    [No Abstract]   [Full Text] [Related]  

  • 8. Course of cases of pulmonary tubercurosis with bacilli resistant to streptmycin, para-aminosalicylic acid and isoniazid and with multiple drug-resistance.
    Oka S
    Sci Rep Res Inst Tohoku Univ Med; 1969 Dec; 16(3):106-9. PubMed ID: 4988512
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug susceptibility of mycobacterium tuberculosis isolates in Asmara.
    Lemma E; Gebre-Yohannes A
    Ethiop Med J; 1984 Apr; 22(2):105-6. PubMed ID: 6202515
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of the geographical spread of drug-resistant tubercle bacilli in a city.
    Tinne JE
    J Med Microbiol; 1971 May; 4(2):P3. PubMed ID: 4998858
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interaction of antitubercular agents. I. Combined action of rifampicin, isonicotinic acid hydrazide, streptomycin and para-aminosalicylic acid on the growth of strains of tubercle bacilli].
    Janowiec M; Zwolska-Kwiek Z; Wiśniewska A; Wróblewska H
    Pneumonol Pol; 1977 Jun; 45(6):425-30. PubMed ID: 406600
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microbacterial resistance to antibiotic preparations].
    Savchenko PIu
    Mikrobiol Zh; 1970; 32(3):376-82. PubMed ID: 4996138
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on infection by drug-resistant tubercle bacilli. 2. Primary drug resistance in children].
    Osato T; Kihara K; Iwasaki T; Shimao T; Fukushima K
    Kekkaku; 1968 Oct; 43(10):431-6. PubMed ID: 4974634
    [No Abstract]   [Full Text] [Related]  

  • 15. [The clinical significance of the critical drug resistance concentration of SM,INH and PAS].
    Baba H; Azuma Y
    Kekkaku; 1972 Oct; 47(10):353-60. PubMed ID: 4658707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current aspects of primary resistance of the tubercle bacillus].
    Canetti G; Le Lirzin M
    Pathol Biol; 1967 Dec; 15(23):1189-95. PubMed ID: 4966389
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pulmonary tuberculosis with resistant bacilli in untreated patients].
    Israel-Asselain R; Chebat J; Baillet A; Malbos J
    Sem Hop; 1965 Oct; 41(40):2227-9. PubMed ID: 4285182
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the problem of the pathogenicity of resistant and atypical mycobacteria in relation to rabbits and chickens].
    Beliakova OI; Shlapak PT; Korzh BA
    Probl Tuberk; 1968; 46(3):56-60. PubMed ID: 4971316
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and drug sensitivity of tubercle bacilli from Addis Ababa, Ethiopia.
    Pattyn SR; Keterew W; Hadgu AG; Van Den Breen L
    Ann Soc Belg Med Trop; 1978; 58(1):59-62. PubMed ID: 98117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.